Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,265
datasets available to search
ShareScore release 0.9.0
Dataset results
1,265 results for “ATOPIC DERMATITIS”
Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
ClinicalTrials.gov study NCT03911401. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA B
ClinicalTrials.gov study NCT02755649. IPD Sharing: Not stated. Countries: 10. Publications: 8.
Study of Apremilast in Atopic or Contact Dermatitis
ClinicalTrials.gov study NCT00931242. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov study NCT03054428. IPD Sharing: Not stated. Countries: 2. Publications: 13.
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
ClinicalTrials.gov study NCT01979016. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT02260986. IPD Sharing: Not stated. Countries: 14. Publications: 23.
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)
ClinicalTrials.gov study NCT03346434. IPD Sharing: Not stated. Countries: 4. Publications: 11.
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Ora
ClinicalTrials.gov study NCT03428100. IPD Sharing: YES. Countries: 14. Publications: 2.
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
ClinicalTrials.gov study NCT01986933. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
ClinicalTrials.gov study NCT02210780. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)
ClinicalTrials.gov study NCT02001181. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)
ClinicalTrials.gov study NCT05194540. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03989349. IPD Sharing: NO. Countries: 11. Publications: 3.
Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis
ClinicalTrials.gov study NCT02589392. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
ClinicalTrials.gov study NCT05032859. IPD Sharing: NO. Countries: 2. Publications: 5.
Targeted Microbiome Transplant in Atopic Dermatitis
ClinicalTrials.gov study NCT03151148. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov study NCT02683928. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05601882. IPD Sharing: YES. Countries: 29. Publications: 1.
Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03334422. IPD Sharing: YES. Countries: 10. Publications: 6.
Open-label Study of Dupilumab in Patients With Atopic Dermatitis
ClinicalTrials.gov study NCT01949311. IPD Sharing: Not stated. Countries: 28. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.